209 related articles for article (PubMed ID: 7989490)
41. Endocrine disorders associated with inappropriately high aromatase expression.
Bulun SE; Noble LS; Takayama K; Michael MD; Agarwal V; Fisher C; Zhao Y; Hinshelwood MM; Ito Y; Simpson ER
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):133-9. PubMed ID: 9365182
[TBL] [Abstract][Full Text] [Related]
42. Porcine hypothalamic aromatase cytochrome P450: isoform characterization, sex-dependent activity, regional expression, and regulation by enzyme inhibition in neonatal boars.
Corbin CJ; Berger T; Ford JJ; Roselli CE; Sienkiewicz W; Trainor BC; Roser JF; Vidal JD; Harada N; Conley AJ
Biol Reprod; 2009 Aug; 81(2):388-95. PubMed ID: 19403926
[TBL] [Abstract][Full Text] [Related]
43. P450 aromatase messenger ribonucleic acid expression in male rat germ cells: detection by reverse transcription-polymerase chain reaction amplification.
Janulis L; Bahr JM; Hess RA; Bunick D
J Androl; 1996; 17(6):651-8. PubMed ID: 9016395
[TBL] [Abstract][Full Text] [Related]
44. Aromatase cytochrome P450: cloning, intron variation, and ontogeny of gene expression in southern flounder (Paralichthys lethostigma).
Luckenbach JA; Early LW; Rowe AH; Borski RJ; Daniels HV; Godwin J
J Exp Zool A Comp Exp Biol; 2005 Aug; 303(8):643-56. PubMed ID: 16013049
[TBL] [Abstract][Full Text] [Related]
45. [Aromatase (P450AROM) mRNA expression in normal, hyperplastic and malignant endometrium and aromatase activity in endometrial cancer tissue culture].
Tarkowski R; Skrzypczak M; Winiarczyk S; Kotarski J; Jakowicki JA; Jakimiuk AJ
Ginekol Pol; 2000 Mar; 71(3):130-5. PubMed ID: 10842913
[TBL] [Abstract][Full Text] [Related]
46. The 5'-flanking region of the ovarian promoter of the bovine CYP19 gene contains a deletion in a cyclic adenosine 3',5'-monophosphate-like responsive sequence.
Hinshelwood MM; Michael MD; Simpson ER
Endocrinology; 1997 Sep; 138(9):3704-10. PubMed ID: 9275055
[TBL] [Abstract][Full Text] [Related]
47. Regulation of aromatase gene expression in purified germ cells of adult male rats: effects of transforming growth factor beta, tumor necrosis factor alpha, and cyclic adenosine 3',5'-monosphosphate.
Bourguiba S; Chater S; Delalande C; Benahmed M; Carreau S
Biol Reprod; 2003 Aug; 69(2):592-601. PubMed ID: 12700195
[TBL] [Abstract][Full Text] [Related]
48. Relative expression of aromatase cytochrome P450 in human fetal tissues as determined by competitive polymerase chain reaction amplification.
Price T; Aitken J; Simpson ER
J Clin Endocrinol Metab; 1992 Apr; 74(4):879-83. PubMed ID: 1548354
[TBL] [Abstract][Full Text] [Related]
49. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
50. Breast cancer and expression of aromatase in breast adipose tissue.
Bulun SE; Simpson ER
Trends Endocrinol Metab; 1994 Apr; 5(3):113-20. PubMed ID: 18407196
[TBL] [Abstract][Full Text] [Related]
51. CYP19 gene expression and aromatase activity in endometrial cancer tissue: importance of the type of the disease.
Berstein L; Zimarina T; Kovalevskij A; Maximov S; Volkov O; Thijssen JH
Neoplasma; 2005; 52(2):115-8. PubMed ID: 15800709
[TBL] [Abstract][Full Text] [Related]
52. Different promoter usage for CYP19 gene expression in buffalo ovary and placenta.
Sharma D; Ghai S; Singh D
Gen Comp Endocrinol; 2009 Jul; 162(3):319-28. PubMed ID: 19375426
[TBL] [Abstract][Full Text] [Related]
53. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4.
Zhao Y; Nichols JE; Valdez R; Mendelson CR; Simpson ER
Mol Endocrinol; 1996 Nov; 10(11):1350-7. PubMed ID: 8923461
[TBL] [Abstract][Full Text] [Related]
54. Developmental regulation of steroidogenic enzyme gene expression in the periimplantation porcine conceptus: a paracrine role for insulin-like growth factor-I.
Green ML; Simmen RC; Simmen FA
Endocrinology; 1995 Sep; 136(9):3961-70. PubMed ID: 7649105
[TBL] [Abstract][Full Text] [Related]
55. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6.
Shozu M; Zhao Y; Bulun SE; Simpson ER
Endocrinology; 1998 Apr; 139(4):1610-7. PubMed ID: 9528941
[TBL] [Abstract][Full Text] [Related]
56. Determination of aromatase cytochrome P450 messenger ribonucleic acid in human breast tissue by competitive polymerase chain reaction amplification.
Price T; Aitken J; Head J; Mahendroo M; Means G; Simpson E
J Clin Endocrinol Metab; 1992 Jun; 74(6):1247-52. PubMed ID: 1592866
[TBL] [Abstract][Full Text] [Related]
57. Hormonal regulation, tissue distribution, and content of aromatase cytochrome P450 messenger ribonucleic acid and enzyme in rat ovarian follicles and corpora lutea: relationship to estradiol biosynthesis.
Hickey GJ; Chen SA; Besman MJ; Shively JE; Hall PF; Gaddy-Kurten D; Richards JS
Endocrinology; 1988 Apr; 122(4):1426-36. PubMed ID: 3126038
[TBL] [Abstract][Full Text] [Related]
58. Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose.
Rubin GL; Duong JH; Clyne CD; Speed CJ; Murata Y; Gong C; Simpson ER
Endocrinology; 2002 Aug; 143(8):2863-71. PubMed ID: 12130549
[TBL] [Abstract][Full Text] [Related]
59. Three different promoters control expression of the aromatase cytochrome p450 gene (cyp19) in mouse gonads and brain.
Golovine K; Schwerin M; Vanselow J
Biol Reprod; 2003 Mar; 68(3):978-84. PubMed ID: 12604651
[TBL] [Abstract][Full Text] [Related]
60. TGF-beta1 stimulates expression of the aromatase (CYP19) gene in human osteoblast-like cells and THP-1 cells.
Shozu M; Zhao Y; Simpson ER
Mol Cell Endocrinol; 2000 Feb; 160(1-2):123-33. PubMed ID: 10715546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
